
As global tensions, tariffs, and foreign ownership controls reshape the biotech landscape, one question demands action: How will we secure America’s bioeconomy?
Join us in Germantown, MD for a special evening edition of Community Connect: After Hours, Montgomery College’s signature biotech networking event hosted by the Pinkney Innovation Complex for Science + Technology (PIC MC) as we explore how workforce, policy, and innovation can strengthen the nation’s biomanufacturing future.
Wednesday, May 13 | 5-7:30 PM
RSVP ➡️ https://luma.com/3q2hib3p
Speakers include:
🔸 Victor Suarez, BioScience & Supply Chain Executive, Global Board Director at ATCC
🔸 Geoffrey Ling, MD, PhD, Founding Director of the Biological Technologies Office at the Defense Advanced Research Projects Agency (DARPA), Jean Ann Brock Distinguished Chair Co-Leader, The BrainHealth Project
🔸 Prashant Panchal, MS, MBA, Director, Business Planning & Operations, AstraZeneca
🔸 Eric Van Gieson, CTO, Equala Therapeutics
🔸 Chris Frew, CEO, BioBuzz
🔸 Thomas Luginbill, Executive Director, PIC MC (moderator)
Together, we’ll break down how onshoring, federal investments, and strategic partnerships are reshaping U.S. competitiveness—and why Maryland is uniquely positioned to lead. Be part of the conversation shaping the next era of American biotechnology, policy, and national security.
#manufacturing #biosecurity #biotech #innovation
Join us in Germantown, MD for a special evening edition of Community Connect: After Hours, Montgomery College’s signature biotech networking event hosted by the Pinkney Innovation Complex for Science + Technology (PIC MC) as we explore how workforce, policy, and innovation can strengthen the nation’s biomanufacturing future.
Wednesday, May 13 | 5-7:30 PM
RSVP ➡️ https://luma.com/3q2hib3p
Speakers include:
🔸 Victor Suarez, BioScience & Supply Chain Executive, Global Board Director at ATCC
🔸 Geoffrey Ling, MD, PhD, Founding Director of the Biological Technologies Office at the Defense Advanced Research Projects Agency (DARPA), Jean Ann Brock Distinguished Chair Co-Leader, The BrainHealth Project
🔸 Prashant Panchal, MS, MBA, Director, Business Planning & Operations, AstraZeneca
🔸 Eric Van Gieson, CTO, Equala Therapeutics
🔸 Chris Frew, CEO, BioBuzz
🔸 Thomas Luginbill, Executive Director, PIC MC (moderator)
Together, we’ll break down how onshoring, federal investments, and strategic partnerships are reshaping U.S. competitiveness—and why Maryland is uniquely positioned to lead. Be part of the conversation shaping the next era of American biotechnology, policy, and national security.
#manufacturing #biosecurity #biotech #innovation
Shared byQuinn Tran - 15 days ago
Log in to comment
Loading ..
Related Articles
BioAnalysis, LLC Appoints Bryan Tsao, PhD as Director of Business Development
AstraZeneca's Dafni Bika Reframes Sustainability in Pharma at MAST Showcase
Exploring Life Sciences Infrastructure with Matt McGrath from Heffron Company
AstraZeneca's $2B Expansion in Maryland: Coordination and Execution Key
Genetic Testing: Early Risk Identification and Informed Care
Join Bre Cameron for Career Catalyst: A Week to Go!
39
0/100